MYGN MYGN

Myriad Genetics Stock Price

18.47
-0.42 (-2.22%)
Upgrade to Real-Time
Regular Market
18.47
Volume 105,678
Bid Price 18.42
Ask Price 18.46
News -
Day High 19.09

Low
16.02

52 Week Range

High
36.9547

Day Low 18.45
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Myriad Genetics Inc MYGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.42 -2.22% 18.47 14:05:00
Open Price Low Price High Price Close Price Prev Close
18.99 18.45 19.09 18.89
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,177 105,678 $ 18.75 $ 1,981,895 - 16.02 - 36.9547
Last Trade Time Type Quantity Stock Price Currency
14:03:48 3 $ 18.45 USD

Period:

Draw Mode:

Myriad Genetics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.49B 80.34M 55.49M $ 690.60M $ -9.39M -0.38 -157.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 268.70k 7.60%

more financials information »

Myriad Genetics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MYGN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week16.6819.48516.6618.36586,9371.7910.73%
1 Month22.7922.7916.0218.03638,583-4.32-18.96%
3 Months25.6925.70516.0220.44552,969-7.22-28.1%
6 Months26.8728.4516.0223.30545,404-8.40-31.26%
1 Year32.6136.954716.0227.09536,540-14.14-43.36%
3 Years26.7448.409.2423.28792,238-8.27-30.93%
5 Years25.6050.449.2427.31812,456-7.13-27.85%

Myriad Genetics Description

Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 35-gene panel with the capability to identify the elevated risk of developing eight types of cancer. Other diagnostic products include BRACAnalysisCDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; Prequel, with is a noninvasive prenatal test; and Prolaris, which identifies prostate cancer patients that can pursue active surveillance. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.


Your Recent History
NASDAQ
MYGN
Myriad Gen..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.